Hassan Bashir Saadia

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The novel aminopeptidase potentiated alkylating agent melflufen, was evaluated for activity in acute myeloid leukemia in a range of in vitro models, as well as in a patient derived xenograft study. All tested AML cell lines were highly sensitive to melflufen while melphalan was considerably less potent. In the HL-60 cell line model, synergy was observed for(More)
  • 1